• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性完全闭塞不是经皮冠状动脉介入治疗成功患者死亡的危险因素:一项队列研究。

Chronic Total Occlusion is Not a Risk Factor for Mortality in Patients With Successful Percutaneous Coronary Intervention: A Cohort Study.

机构信息

Department of Cardiology Aarhus University Hospital Aarhus Denmark.

Institute of Clinical Medicine Aarhus University Aarhus Denmark.

出版信息

J Am Heart Assoc. 2023 Oct 17;12(20):e030989. doi: 10.1161/JAHA.123.030989. Epub 2023 Oct 13.

DOI:10.1161/JAHA.123.030989
PMID:37830355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10757529/
Abstract

Background Fifteen percent of patients with coronary artery disease undergoing angiography have a chronic total occlusion (CTO). The current study aimed to investigate the long-term prognosis after successful and unsuccessful CTO percutaneous coronary intervention (PCI) compared with PCI for non-CTO lesions. Methods and Results The current study was designed as an observational, region-wide, register-based cohort study enrolling all patients undergoing PCI in the Central Region of Denmark in 2009 to 2019. Patients were stratified into non-CTO, successful CTO, and unsuccessful CTO revascularization. Patients were followed until an event or January 1, 2022. The primary end point was all-cause mortality. In 21 141 patients enrolled, 2108 underwent CTO PCI. Clinical presentation was acute coronary syndrome in 11 879 patients and chronic coronary syndrome in 7887 patients. After a median of 5.7 years (interquartile range, 3.3-8.8), long-term all-cause mortality was higher after CTO PCI compared with non-CTO PCI, but the difference was statistically insignificant when adjusting for clinical factors (unadjusted hazard ratio [HR], 1.19 [95% CI, 1.09-1.29], adjusted HR, 1.08 [95% CI, 0.97-1.20]; =0.165). After successful CTO PCI, no difference compared with non-CTO PCI was observed (unadjusted HR, 0.99 [95% CI, 0.90-1.10], adjusted HR, 0.99 [95% CI, 0.87-1.12]; =0.873). After unsuccessful CTO PCI, long-term all-cause mortality was higher than non-CTO PCI (unadjusted HR, 1.82 [95% CI, 1.59-2.08], adjusted HR, 1.35 [95% CI, 1.13-1.63]; <0.001). Conclusions Patients undergoing PCI for CTO have elevated long-term mortality compared with patients without CTO. Successful opening of the CTO(s) is associated with equal mortality compared with non-CTO PCI. In contrast, failed CTO PCI is associated with worse long-term mortality. These findings suggest the need for CTO programs with high success rates and low complication rates.

摘要

背景

接受血管造影的冠状动脉疾病患者中有 15%存在慢性完全闭塞(CTO)。本研究旨在比较 CTO 经皮冠状动脉介入治疗(PCI)成功和不成功与非 CTO 病变 PCI 的长期预后。

方法和结果

本研究设计为一项观察性、全区域、基于登记的队列研究,纳入 2009 年至 2019 年在丹麦中部地区接受 PCI 的所有患者。患者分为非 CTO、成功 CTO 和不成功 CTO 血运重建。患者随访至发生事件或 2022 年 1 月 1 日。主要终点为全因死亡率。在纳入的 21087 例患者中,2108 例行 CTO PCI。11879 例患者的临床表现为急性冠状动脉综合征,7887 例患者为慢性冠状动脉综合征。中位随访 5.7 年后(四分位距,3.3-8.8),与非 CTO PCI 相比,CTO PCI 后长期全因死亡率更高,但调整临床因素后差异无统计学意义(未调整的危险比[HR],1.19 [95%CI,1.09-1.29],调整的 HR,1.08 [95%CI,0.97-1.20];=0.165)。成功 CTO PCI 后与非 CTO PCI 无差异(未调整的 HR,0.99 [95%CI,0.90-1.10],调整的 HR,0.99 [95%CI,0.87-1.12];=0.873)。不成功 CTO PCI 后,全因死亡率高于非 CTO PCI(未调整的 HR,1.82 [95%CI,1.59-2.08],调整的 HR,1.35 [95%CI,1.13-1.63];<0.001)。

结论

与无 CTO 的患者相比,接受 CTO PCI 的患者有更高的长期死亡率。成功开通 CTO 与非 CTO PCI 死亡率相等。相比之下,CTO PCI 失败与长期死亡率恶化相关。这些发现表明需要 CTO 计划具有高成功率和低并发症率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/10757529/4c392d0e5d26/JAH3-12-e030989-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/10757529/b197ccf2fac6/JAH3-12-e030989-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/10757529/5f6a59d39c7c/JAH3-12-e030989-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/10757529/440064e6afd2/JAH3-12-e030989-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/10757529/f37ece10b993/JAH3-12-e030989-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/10757529/53d7c08ee549/JAH3-12-e030989-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/10757529/4c392d0e5d26/JAH3-12-e030989-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/10757529/b197ccf2fac6/JAH3-12-e030989-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/10757529/5f6a59d39c7c/JAH3-12-e030989-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/10757529/440064e6afd2/JAH3-12-e030989-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/10757529/f37ece10b993/JAH3-12-e030989-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/10757529/53d7c08ee549/JAH3-12-e030989-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a846/10757529/4c392d0e5d26/JAH3-12-e030989-g005.jpg

相似文献

1
Chronic Total Occlusion is Not a Risk Factor for Mortality in Patients With Successful Percutaneous Coronary Intervention: A Cohort Study.慢性完全闭塞不是经皮冠状动脉介入治疗成功患者死亡的危险因素:一项队列研究。
J Am Heart Assoc. 2023 Oct 17;12(20):e030989. doi: 10.1161/JAHA.123.030989. Epub 2023 Oct 13.
2
Long term clinical outcome after success re-attempt percutaneous coronary intervention of chronic total occlusion.慢性完全闭塞病变经皮冠状动脉介入治疗成功后再尝试的长期临床结果。
BMC Cardiovasc Disord. 2023 Jan 16;23(1):23. doi: 10.1186/s12872-023-03045-w.
3
Long-term outcomes after revascularization in chronic total and non-total occluded coronary arteries: A regionwide cohort study.慢性全闭塞和非全闭塞冠状动脉血运重建后的长期结果:一项区域范围的队列研究。
PLoS One. 2024 Jul 15;19(7):e0307264. doi: 10.1371/journal.pone.0307264. eCollection 2024.
4
Survival after percutaneous coronary intervention for chronic total occlusion.经皮冠状动脉介入治疗慢性完全闭塞病变后的生存率。
Clin Res Cardiol. 2016 Nov;105(11):921-929. doi: 10.1007/s00392-016-1000-2. Epub 2016 Jun 1.
5
Long-term outcomes of percutaneous coronary intervention for in-stent chronic total occlusion.经皮冠状动脉介入治疗支架内慢性完全闭塞的长期结果。
Chin Med J (Engl). 2020 Dec 16;134(3):302-308. doi: 10.1097/CM9.0000000000001289.
6
Successful versus unsuccessful antegrade recanalization of single chronic coronary occlusion: eight-year experience and outcomes by a propensity score ascertainment.单支慢性冠状动脉闭塞成功与不成功的顺行再通:倾向评分确定法的八年经验及结果
Catheter Cardiovasc Interv. 2015 Aug;86(2):E49-57. doi: 10.1002/ccd.25841. Epub 2015 Mar 24.
7
Successful Recanalization of Native Coronary Chronic Total Occlusion Is Not Associated With Improved Long-Term Survival.原位冠状动脉慢性完全闭塞再通与长期生存改善无关。
JACC Cardiovasc Interv. 2016 Mar 28;9(6):530-8. doi: 10.1016/j.jcin.2015.11.016. Epub 2016 Mar 2.
8
Ischemic Burden Reduction and Long-Term Clinical Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention.慢性完全闭塞经皮冠状动脉介入治疗后缺血负担减少与长期临床结局。
JACC Cardiovasc Interv. 2021 Jul 12;14(13):1407-1418. doi: 10.1016/j.jcin.2021.04.044.
9
Impact of anemia on long-term outcomes after percutaneous coronary intervention for chronic total occlusion.贫血对慢性完全闭塞性病变经皮冠状动脉介入治疗后长期预后的影响。
Catheter Cardiovasc Interv. 2018 Feb 1;91(2):226-233. doi: 10.1002/ccd.27412. Epub 2017 Nov 11.
10
Over Ten Years' Follow-Up of Chronic Total Coronary Occlusion Angioplasty.慢性完全闭塞性冠状动脉病变经皮血管成形术的十年随访。
Cardiovasc Revasc Med. 2021 Apr;25:44-46. doi: 10.1016/j.carrev.2020.10.013. Epub 2020 Oct 29.

引用本文的文献

1
Myocardial Infarction and All-Cause Mortality Following Percutaneous Coronary Intervention Versus Conservative Treatment of Chronic Total Occlusions: A West Denmark Heart Registry Study.经皮冠状动脉介入治疗与慢性完全闭塞病变保守治疗后的心肌梗死及全因死亡率:丹麦西部心脏注册研究
Catheter Cardiovasc Interv. 2025 May;105(6):1296-1303. doi: 10.1002/ccd.31454. Epub 2025 Feb 19.
2
Long-term outcomes after revascularization in chronic total and non-total occluded coronary arteries: A regionwide cohort study.慢性全闭塞和非全闭塞冠状动脉血运重建后的长期结果:一项区域范围的队列研究。
PLoS One. 2024 Jul 15;19(7):e0307264. doi: 10.1371/journal.pone.0307264. eCollection 2024.
3

本文引用的文献

1
Long-Term Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention Among Medicare Beneficiaries.医疗保险受益人群中慢性完全闭塞性经皮冠状动脉介入治疗的长期结果
J Soc Cardiovasc Angiogr Interv. 2023 Jan 26;2(2):100584. doi: 10.1016/j.jscai.2023.100584. eCollection 2023 Mar-Apr.
2
Early and long-term prognosis in patients with remaining chronic total occlusions after revascularization attempt. A cohort study from the SKEJ-CTO registry.经血运重建尝试后仍存在慢性完全闭塞患者的早期和长期预后。来自 SKEJ-CTO 注册研究的队列研究。
Scand Cardiovasc J. 2023 Dec;57(1):17-24. doi: 10.1080/14017431.2022.2150787.
3
Survival Following Recanalization of Chronic Total Occlusion: The Devil Is in the Details.
慢性完全闭塞病变再通后的生存情况:细节决定成败。
J Am Heart Assoc. 2023 Oct 17;12(20):e032178. doi: 10.1161/JAHA.123.032178. Epub 2023 Oct 13.
International randomized trial on the effect of revascularization or optimal medical therapy of chronic total coronary occlusions with myocardial ischemia - ISCHEMIA-CTO trial - rationale and design.
国际随机临床试验观察慢性完全闭塞性冠状动脉病变合并心肌缺血患者血运重建与最佳药物治疗的疗效 - ISCHEMIA-CTO 试验:理论基础与设计
Am Heart J. 2023 Mar;257:41-50. doi: 10.1016/j.ahj.2022.11.016. Epub 2022 Nov 21.
4
Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery Occlusions.完全性冠状动脉闭塞患者经皮或手术血运重建 10 年后的死亡率。
J Am Coll Cardiol. 2021 Feb 9;77(5):529-540. doi: 10.1016/j.jacc.2020.11.055.
5
Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations.冠状动脉慢性完全闭塞病变治疗的定义和临床试验设计原则:CTO-ARC 共识建议。
Circulation. 2021 Feb 2;143(5):479-500. doi: 10.1161/CIRCULATIONAHA.120.046754. Epub 2021 Feb 1.
6
Why and How Should We Treat Chronic Total Occlusion? Evolution of State-of-the-Art Methods and Future Directions.为何以及如何治疗慢性完全闭塞?最先进方法的演变和未来方向。
Can J Cardiol. 2022 Oct;38(10 Suppl1):S42-S53. doi: 10.1016/j.cjca.2020.10.005. Epub 2020 Oct 17.
7
Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysis.随机临床试验中经皮介入治疗与冠状动脉旁路移植术的总体死亡率和死因特异性死亡率:一项荟萃分析。
JAMA Intern Med. 2020 Dec 1;180(12):1638-1646. doi: 10.1001/jamainternmed.2020.4748.
8
Initial Invasive or Conservative Strategy for Stable Coronary Disease.稳定型冠心病的初始侵入性或保守治疗策略。
N Engl J Med. 2020 Apr 9;382(15):1395-1407. doi: 10.1056/NEJMoa1915922. Epub 2020 Mar 30.
9
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.2019年欧洲心脏病学会慢性冠状动脉综合征诊断和管理指南
Eur Heart J. 2020 Jan 14;41(3):407-477. doi: 10.1093/eurheartj/ehz425.
10
Examining the Operator Learning Curve for Percutaneous Coronary Intervention of Chronic Total Occlusions.检查经皮冠状动脉介入治疗慢性完全闭塞的术者学习曲线。
Circ Cardiovasc Interv. 2019 Aug;12(8):e007877. doi: 10.1161/CIRCINTERVENTIONS.119.007877. Epub 2019 Aug 16.